Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Neurology"
DOI: 10.1007/s00415-019-09257-5
Abstract: Alemtuzumab (ATZ) is an established highly effective treatment in relapsing-remitting multiple sclerosis (RRMS) [1–3]. Secondary autoimmune disorders in MS patients treated with alemtuzumab have been reported in a frequency of about 40% for thyroid disorders,… read more here.
Keywords: secondary autoimmune; treatment; autoimmune disease; alemtuzumab ... See more keywords
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines11010044
Abstract: The most recent International League Against Epilepsy (ILAE) classification has included “immune etiology” along with other well-known causes of epilepsy. This was possible thanks to the progress in detection of pathogenic neural antibodies (Abs) in… read more here.
Keywords: autoimmune encephalitis; secondary autoimmune; seizures epilepsy; epilepsy norse ... See more keywords